Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Tyra Biosciences
TYRA
$1.37B
| $752K | ﹤0.01% |
34,399
-29,406
| -46% | -$808K |
2025 Q2
5 quarters
|
|
3002
PUT
Yum! Brands
YUM
$42.7B
| $750K | ﹤0.01% |
+5,500
| New | +$823K |
2026 Q3
0 quarters
|
|
3003
CALL
Amprius Technologies
AMPX
$1.22B
| $748K | ﹤0.01% |
77,300
-42,500
| -35% | -$444K |
2026 Q1
2 quarters
|
|
3004
CALL
Celcuity
CELC
$3.14B
| $747K | ﹤0.01% |
+9,400
| New | +$855K |
2026 Q3
0 quarters
|
|
3005
XPeng
XPEV
$9.06B
| $746K | ﹤0.01% |
78,070
+6,824
| +10% | +$80.7K |
2025 Q4
3 quarters
|
|
3006
Health Catalyst
HCAT
$104M
| $746K | ﹤0.01% |
431,373
+31,163
| +8% | +$59.5K |
2025 Q1
6 quarters
|
|
3007
NiSource
NI
$22B
| $745K | ﹤0.01% |
19,110
-27,235
| -59% | -$1.17M |
2019 Q2
29 quarters
|
|
3008
TD Synnex
SNX
$19.3B
| $745K | ﹤0.01% |
+2,900
| New | +$740K |
2026 Q3
0 quarters
|
|
3009
CALL
Olin
OLN
$2.01B
| $744K | ﹤0.01% |
+48,000
| New | +$910K |
2026 Q3
0 quarters
|
|
3010
CALL
iShares Russell 1000 Value ETF
IWD
$84.7B
| $744K | ﹤0.01% |
+3,000
| New | +$758K |
2026 Q3
0 quarters
|
|
3011
Procept Biorobotics
PRCT
$1.35B
| $744K | ﹤0.01% |
40,816
+14,386
| +54% | +$287K |
2026 Q2
1 quarter
|
|
3012
PUT
International Flavors & Fragrances
IFF
$20.1B
| $743K | ﹤0.01% |
+8,900
| New | +$734K |
2026 Q3
0 quarters
|
|
3013
VanEck Oil Services ETF
OIH
$1.81B
| $740K | ﹤0.01% |
1,956
-41,271
| -95% | -$16.4M |
2026 Q2
1 quarter
|
|
3014
New Jersey Resources
NJR
$5.58B
| $739K | ﹤0.01% |
+14,613
| New | +$809K |
2026 Q3
0 quarters
|
|
3015
Norwood Financial Corp
NWFL
$393M
| $739K | ﹤0.01% |
22,367
-3,635
| -14% | -$122K |
2025 Q4
3 quarters
|
|
3016
ESCO Technologies
ESE
$6.1B
| $739K | ﹤0.01% |
2,786
-7,857
| -74% | -$2.33M |
2025 Q4
3 quarters
|
|
3017
CALL
Sterling Infrastructure
STRL
$9.2B
| $738K | ﹤0.01% |
1,500
-3,700
| -71% | -$2.08M |
2025 Q4
3 quarters
|
|
3018
Centerra Gold
CGAU
$3.93B
| $737K | ﹤0.01% |
+33,830
| New | +$681K |
2026 Q3
0 quarters
|
|
3019
Greenlight Captial
GLRE
$527M
| $736K | ﹤0.01% |
+50,725
| New | +$801K |
2026 Q3
0 quarters
|
|
3020
Manitowoc
MTW
$880M
| $733K | ﹤0.01% |
34,167
+6,564
| +24% | +$116K |
2025 Q3
4 quarters
|
|
3021
First Community Corp
FCCO
$308M
| $732K | ﹤0.01% |
22,769
-49,695
| -69% | -$1.67M |
2024 Q4
7 quarters
|
|
|
ATTO
3022
Attovia Therapeutics
ATTO
$723M
| $732K | ﹤0.01% |
+42,725
| New | +$899K |
2026 Q3
0 quarters
|
|
3023
CALL
Hut 8
HUT
$7.44B
| $732K | ﹤0.01% |
8,500
-120,100
| -93% | -$11.4M |
2026 Q2
1 quarter
|
|
3024
CALL
Star Bulk Carriers
SBLK
$3.3B
| $731K | ﹤0.01% |
24,900
+2,700
| +12% | +$78.2K |
2026 Q2
1 quarter
|
|
3025
QuidelOrtho
QDEL
$729M
| $730K | ﹤0.01% |
69,262
-15,989
| -19% | -$235K |
2026 Q2
1 quarter
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.